APTO
Income statement / Annual
Last year (2024), Aptose Biosciences Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Aptose Biosciences Inc.'s net income was -$25.43 M.
See Aptose Biosciences Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$474.55 K
|
$507.08 K
|
$616.53 K
|
$646.44 K
|
$627.25 K
|
$83.51 K
|
$89.09 K
|
$114.84 K
|
$69.11 K
|
| Gross Profit |
$0.00
|
-$474.55 K
|
-$507.08 K
|
-$616.53 K
|
-$646.44 K
|
-$627.25 K
|
-$83.51 K
|
-$89.09 K
|
-$114.84 K
|
-$69.11 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$15.10 M
|
$36.77 M
|
$28.09 M
|
$45.99 M
|
$29.29 M
|
$16.84 M
|
$18.73 M
|
$6.27 M
|
$7.66 M
|
$4.48 M
|
| General & Administrative Expenses |
$11.15 M
|
$15.59 M
|
$14.51 M
|
$19.46 M
|
$26.48 M
|
$10.02 M
|
$10.37 M
|
$5.50 M
|
$6.13 M
|
$7.05 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$11.15 M
|
$15.59 M
|
$14.51 M
|
$19.46 M
|
$26.48 M
|
$10.02 M
|
$10.37 M
|
$5.50 M
|
$6.13 M
|
$7.05 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$26.26 M
|
$52.36 M
|
$42.60 M
|
$65.45 M
|
$55.77 M
|
$26.86 M
|
$29.11 M
|
$11.83 M
|
$13.80 M
|
$11.52 M
|
| Cost And Expenses |
$0.00
|
$52.36 M
|
$42.60 M
|
$65.45 M
|
$55.77 M
|
$26.86 M
|
$29.11 M
|
$11.83 M
|
$13.92 M
|
$11.59 M
|
| Interest Income |
$357.00 K
|
$1.15 M
|
$788.00 K
|
$94.00 K
|
$522.00 K
|
$574.00 K
|
$283.00 K
|
$165.00 K
|
$78.12 K
|
$205.89 K
|
| Interest Expense |
-$207.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$49.10 K
|
$30.99 K
|
| Depreciation & Amortization |
$0.00
|
$88.00 K
|
$120.00 K
|
$150.00 K
|
$646.44 K
|
$613.00 K
|
$83.51 K
|
$89.09 K
|
$114.84 K
|
$69.11 K
|
| EBITDA |
$0.00 |
-$52.27 M |
-$42.48 M |
-$65.30 M |
-$55.12 M |
-$26.26 M |
-$29.02 M |
-$11.74 M |
-$13.78 M |
-$10.43 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
$1.15 M
|
$779.00 K
|
$93.00 K
|
$530.00 K
|
$580.00 K
|
$239.00 K
|
$165.00 K
|
$29.02 K
|
$1.06 M
|
| Income Before Tax |
-$25.43 M
|
-$51.21 M
|
-$41.82 M
|
-$65.35 M
|
-$55.24 M
|
-$26.28 M
|
-$28.87 M
|
-$11.66 M
|
-$13.86 M
|
-$10.54 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$18.00 K
|
$31.52 K
|
$30.99 K
|
| Net Income |
-$25.43 M
|
-$51.21 M
|
-$41.82 M
|
-$65.35 M
|
-$55.24 M
|
-$26.28 M
|
-$28.87 M
|
-$11.66 M
|
-$13.86 M
|
-$10.54 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-5.73 |
-7.58 |
-6.8 |
-11.01 |
-9.3 |
-7.86 |
-12.97 |
-7.84 |
-16.31 |
-13.28 |
| EPS Diluted |
-18.94 |
-27.08 |
-22.12 |
-34.56 |
-29.21 |
-7.86 |
-12.97 |
-7.84 |
-16.31 |
-13.28 |
| Weighted Average Shares Out |
$4.44 M
|
$6.76 M
|
$6.15 M
|
$5.94 M
|
$5.94 M
|
$3.34 M
|
$2.23 M
|
$1.49 M
|
$849.53 K
|
$793.73 K
|
| Weighted Average Shares Out Diluted |
$1.34 M
|
$1.89 M
|
$1.89 M
|
$1.89 M
|
$1.89 M
|
$3.34 M
|
$2.23 M
|
$1.49 M
|
$849.53 K
|
$793.73 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
